As awareness of canine cognitive decline grows, validated, science-backed solutions are becoming indispensable. Bill Mohri, Founder & CEO of SoluPet, shares how the company translates neuroscience research into a veterinary supplement, using data-driven validation to establish a science-backed category of care in canine animal health.
Nutrition
Canine
Supplements
Science-Based
Bill Mohri
Founder and CEO
SoluPet Supplements
Breaking into the animal health vaccines market requires overcoming high regulatory barriers and providing speed in response to outbreaks and evolving variants. Hanjo Hennemann shares how VEROVACCiNES leveraged a recombinant platform to rapidly design, test, and scale vaccines utilising regulatory pathways for broader and faster market entry.
Milestone - Platform Technology
Vaccine
Biopharma
Livestock
Late-Stage VC
Regulation
Hanjo Hennemann
CEO
VEROVACCiNES
A well-timed bridge investment can mean the difference between stalling and scaling. Dr. Asel Sartbaeva, CEO and co-founder of EnsiliTech, reflects on how family office support provided crucial bridge, enabled better deal terms, and positioned the company to close an oversubscribed £4.5 million round.
Showcase Finalist
Milestone - Bridge Funding
Funding
Family Office
Companion
Livestock
Biopharma
Seed
Prevention
Treatement
Asel Sartbaeva
CEO
EnsiliTech
Candise Goodwin
Founder
Outlier Advisors
Candise Goodwin is a recognized leader in the pet industry, with over 15 years of experience helping companies navigate market complexity, scale solutions, and deliver measurable impact. Her background spans pivotal roles at industry leaders including Merck Animal Health, Vets First Choice, VIP Petcare/PETIQ, and Petco, where she led major digital transformations and launched numerous high-profile, industry-changing growth initiatives.
Candise has dedicated her career to understanding the challenges and opportunities within the pet industry. She has worked closely with retailers, veterinary groups, pet technology companies, product and service providers, and pharmacies - developing a holistic, customer-centric viewpoint of the industry's unique ecosystem along the way.
Today, Candise extends her expertise to clients seeking to navigate the complexities of the market. Her firm, Outlier Advisors, provides strategic consulting services that reflect her distinctive blend of innovative thinking, deep industry knowledge, and ability to spot emerging trends. Outlier Advisors partners with industry leaders, investors, and startups to develop actionable strategies that meet the demands of an evolving pet landscape.
Candise is also a sought-after speaker, advisor, author, and mentor, known for sharing rare and multifaceted insights and practical strategies with fellow Outliers.
Bringing the world’s first insect vaccine from discovery to commercial reality marks a defining milestone for Dalan Animal Health. Annette Kleiser, CEO, shares how Dalan is now applying its innate immunity platform to aquaculture, advancing proof-of-concept in shrimp, and exploring broader species application.
Aquaculture
Scale
Bee
Vaccine
Platform
Proof-of-Concept
Annette Kleiser
CEO
Dalan
Approval alone doesn’t guarantee commercial success. Robert Jordan shares how Vetirus Pharmaceuticals combines in-house regulatory expertise with early manufacturing planning, ensuring supply, shortening timelines to revenue, and enabling global expansion.
Milestone - Manufacturing
Regulation
Supply Chain
Biopharma
Regenerative Medicine
Robert Jordan
CEO
Vetirus Animal Health